Although existing treatments allow a full life with the HIV virus, now, more than ever, scientists are close to developing a mechanism that will completely remove the virus from the body.

Victor Appay, PhD, explains how long-term ART slows immune aging, boosting HIV viral suppression and paving the way for ...

Novartis is the second drug company to settle a lawsuit brought by the family of a woman whose cells have enabled huge advances in science.

Melissa Schnure, PhD, wants to make sure some of the country’s most vulnerable patients are protected — low-income people living with HIV who depend on federally funded HIV services.It is why Schnure, ...

Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), a Once-Daily, Two-Drug Regimen at CROI 2026 ...

For more than 40 years, scientists have chased a virus that refuses to stand still. HIV mutates quickly, hiding in long-lived cells and forming what are known as viral reservoirs, one of the main ...

IMPAACT 2017 (MOCHA) week 96 results show long-acting Cabenuva (cabotegravir + rilpivirine) effectively maintained viral suppression in 94.4% of adolescents aged 12 to <18 years Additional paediatric ...

The iPhone 18 Pro is expected to get a slew of battery, camera, and chip upgrades. Bloomberg now reports that it could come adorned in a deep color, as well. The post The iPhone 18 Pro’s signature ...

Researchers from Brown University and the University of Rochester will lead a multi-institution project to test whether ...

For much of modern biology, scientists argued that viruses are not alive, pointing to a basic limitation: they cannot make proteins on their own and must depend entirely on the cells they infect for ...

A review published in Infection highlights viral mimic systems that safely replicate key features of pathogens like SARS-CoV-2. These technologies allow vaccine testing in lower-level biosafety ...